| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
hydroxysteroid 11-beta dehydrogenase 2 | 0.532 | 0.808 | 0.12 |
|
group | 0.700 | None | 0.964 | 50 | 2 | 1995 | 2019 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
group | 0.600 | None | 0.982 | 49 | 6 | 2003 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
group | 0.400 | None | 0.943 | 49 | 4 | 2002 | 2020 | ||||||||
|
WNK lysine deficient protein kinase 4 | 0.644 | 0.538 | 6.9E-25 |
|
group | 0.500 | None | 0.909 | 42 | 2 | 2003 | 2020 | ||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
group | 0.100 | None | 0.923 | 39 | 1 | 1995 | 2019 | |||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
group | 0.100 | None | 0.974 | 39 | 0 | 2003 | 2020 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
group | 0.300 | None | 0.933 | 37 | 5 | 1989 | 2017 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
group | 0.100 | None | 1.000 | 37 | 0 | 1999 | 2020 | |||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
group | 0.100 | None | 0.943 | 35 | 0 | 2007 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.100 | None | 0.914 | 35 | 0 | 1995 | 2019 | ||||||||
|
solute carrier family 33 member 1 | 0.529 | 0.769 | 9.9E-05 |
|
group | 0.100 | None | 0.914 | 35 | 0 | 1995 | 2019 | ||||||||
|
solute carrier family 12 member 3 | 0.493 | 0.808 | 3.0E-32 |
|
group | 0.400 | None | 1.000 | 33 | 7 | 2001 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
group | 0.600 | None | 0.889 | 32 | 1 | 1998 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.600 | None | 1.000 | 32 | 3 | 1996 | 2020 | ||||||||
|
bone morphogenetic protein receptor type 2 | 0.538 | 0.654 | 1.00 |
|
group | 0.200 | None | 1.000 | 31 | 1 | 2002 | 2020 | ||||||||
|
apolipoprotein L1 | 0.547 | 0.615 | 5.1E-06 |
|
group | 0.100 | None | 1.000 | 30 | 0 | 2010 | 2019 | ||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
group | 0.200 | None | 1.000 | 29 | 4 | 1998 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.600 | None | 0.968 | 28 | 1 | 2002 | 2019 | ||||||||
|
apelin | 0.497 | 0.769 | 0.46 |
|
group | 0.300 | None | 0.897 | 28 | 5 | 2005 | 2019 | ||||||||
|
cytochrome P450 family 4 subfamily A member 11 | 0.695 | 0.462 | 1.1E-24 |
|
group | 0.300 | None | 1.000 | 25 | 5 | 2005 | 2018 | ||||||||
|
WNK lysine deficient protein kinase 1 | 0.416 | 0.846 | 1.00 |
|
group | 0.500 | None | 0.963 | 25 | 5 | 2003 | 2020 | ||||||||
|
ATPase H+ transporting accessory protein 2 | 0.525 | 0.769 | 0.87 |
|
group | 0.300 | None | 0.960 | 24 | 1 | 2007 | 2019 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
group | 0.300 | None | 1.000 | 24 | 0 | 2000 | 2019 | ||||||||
|
serine/threonine kinase 39 | 0.670 | 0.500 | 1.00 |
|
group | 0.400 | None | 0.920 | 24 | 4 | 2008 | 2019 | ||||||||
|
natriuretic peptide A | 0.505 | 0.769 | 5.5E-04 |
|
group | 0.600 | None | 0.970 | 24 | 3 | 1989 | 2019 |